Evaluates treatment patterns and healthcare resource utilization in adult patients with generalized myasthenia gravis, indicating potential implications for care improvements.
To evaluate generalized myasthenia gravis (gMG) treatment patterns and healthcare resource utilization (HCRU) in adult patients who initiated rozanolixizumab in the USA.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: